XML 28 R32.htm IDEA: XBRL DOCUMENT v3.19.3

Supplemental Condensed Consolidating Financial Information (Tables)

9 Months Ended

Sep. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Condensed Consolidating Comprehensive Income Statement

HCA HEALTHCARE, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED SEPTEMBER 30, 2019

(Dollars in millions)

		HCA Healthcare, Inc. Issuer				HCA Inc. Issuer				Subsidiary Guarantors				Subsidiary Non- Guarantors				Eliminations				Condensed Consolidated
Revenues		$	—			$	—			$	7,196			$	5,498			$	—			$	12,694
Salaries and benefits			—				—				3,272				2,699				—				5,971
Supplies			—				—				1,174				916				—				2,090
Other operating expenses			4				—				1,178				1,170				—				2,352
Equity in earnings of affiliates			(656	)			—				(2	)			(2	)			656				(4	)
Depreciation and amortization			—				—				362				285				—				647
Interest expense (income)			16				1,014				(505	)			(77	)			—				448
Losses (gains) on sales of facilities			—				—				(2	)			2				—				—
Losses on retirement of debt			—				211				—				—				—				211
Management fees			—				—				(197	)			197				—				—
			(636	)			1,225				5,280				5,190				656				11,715
Income (loss) before income taxes			636				(1,225	)			1,916				308				(656	)			979
Provision (benefit) for income taxes			24				(279	)			429				41				—				215
Net income (loss)			612				(946	)			1,487				267				(656	)			764
Net income attributable to noncontrolling interests			—				—				23				129				—				152
Net income (loss) attributable to HCA Healthcare, Inc.		$	612			$	(946	)		$	1,464			$	138			$	(656	)		$	612
Comprehensive income (loss) attributable to HCA Healthcare, Inc.		$	582			$	(954	)		$	1,467			$	113			$	(626	)		$	582

HCA HEALTHCARE, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED SEPTEMBER 30, 2018

(Dollars in millions)

		HCA Healthcare, Inc. Issuer				HCA Inc. Issuer				Subsidiary Guarantors				Subsidiary Non- Guarantors				Eliminations				Condensed Consolidated
Revenues		$	—			$	—			$	6,747			$	4,704			$	—			$	11,451
Salaries and benefits			—				—				3,090				2,287				—				5,377
Supplies			—				—				1,115				775				—				1,890
Other operating expenses			2				—				1,137				958				—				2,097
Equity in earnings of affiliates			(728	)			—				(2	)			(7	)			728				(9	)
Depreciation and amortization			—				—				340				242				—				582
Interest expense (income)			16				913				(423	)			(64	)			—				442
Losses (gains) on sales of facilities			—				—				(6	)			—				—				(6	)
Losses on retirement of debt			—				9				—				—				—				9
Management fees			—				—				(158	)			158				—				—
			(710	)			922				5,093				4,349				728				10,382
Income (loss) before income taxes			710				(922	)			1,654				355				(728	)			1,069
Provision (benefit) for income taxes			(49	)			(214	)			379				57				—				173
Net income (loss)			759				(708	)			1,275				298				(728	)			896
Net income attributable to noncontrolling interests			—				—				22				115				—				137
Net income (loss) attributable to HCA Healthcare, Inc.		$	759			$	(708	)		$	1,253			$	183			$	(728	)		$	759
Comprehensive income (loss) attributable to HCA Healthcare, Inc.		$	754			$	(703	)		$	1,258			$	168			$	(723	)		$	754

HCA HEALTHCARE, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019

(Dollars in millions)

		HCA Healthcare, Inc. Issuer				HCA Inc. Issuer				Subsidiary Guarantors				Subsidiary Non- Guarantors				Eliminations				Condensed Consolidated
Revenues		$	—			$	—			$	21,549			$	16,264			$	—			$	37,813
Salaries and benefits			—				—				9,608				7,847				—				17,455
Supplies			—				—				3,540				2,709				—				6,249
Other operating expenses			7				—				3,481				3,525				—				7,013
Equity in earnings of affiliates			(2,504	)			—				(5	)			(18	)			2,504				(23	)
Depreciation and amortization			—				—				1,071				831				—				1,902
Interest expense (income)			48				3,019				(1,489	)			(192	)			—				1,386
Gains on sales of facilities			—				—				(9	)			(8	)			—				(17	)
Losses on retirement of debt			—				211				—				—				—				211
Management fees			—				—				(573	)			573				—				—
			(2,449	)			3,230				15,624				15,267				2,504				34,176
Income (loss) before income taxes			2,449				(3,230	)			5,925				997				(2,504	)			3,637
Provision (benefit) for income taxes			15				(745	)			1,351				144				—				765
Net income (loss)			2,434				(2,485	)			4,574				853				(2,504	)			2,872
Net income attributable to noncontrolling interests			—				—				64				374				—				438
Net income (loss) attributable to HCA Healthcare, Inc.		$	2,434			$	(2,485	)		$	4,510			$	479			$	(2,504	)		$	2,434
Comprehensive income (loss) attributable to HCA Healthcare, Inc.		$	2,354			$	(2,542	)		$	4,518			$	448			$	(2,424	)		$	2,354

HCA HEALTHCARE, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2018

(Dollars in millions)

		HCA Healthcare, Inc. Issuer				HCA Inc. Issuer				Subsidiary Guarantors				Subsidiary Non- Guarantors				Eliminations				Condensed Consolidated
Revenues		$	—			$	—			$	20,297			$	14,106			$	—			$	34,403
Salaries and benefits			—				—				9,184				6,756				—				15,940
Supplies			—				—				3,383				2,339				—				5,722
Other operating expenses			7				—				3,387				2,931				—				6,325
Equity in earnings of affiliates			(2,670	)			—				(5	)			(20	)			2,670				(25	)
Depreciation and amortization			—				—				992				705				—				1,697
Interest expense (income)			48				2,617				(1,179	)			(177	)			—				1,309
Gains on sales of facilities			—				—				(378	)			(42	)			—				(420	)
Losses on retirement of debt			—				9				—				—				—				9
Management fees			—				—				(473	)			473				—				—
			(2,615	)			2,626				14,911				12,965				2,670				30,557
Income (loss) before income taxes			2,615				(2,626	)			5,386				1,141				(2,670	)			3,846
Provision (benefit) for income taxes			(108	)			(610	)			1,235				185				—				702
Net income (loss)			2,723				(2,016	)			4,151				956				(2,670	)			3,144
Net income attributable to noncontrolling interests			—				—				72				349				—				421
Net income (loss) attributable to HCA Healthcare, Inc.		$	2,723			$	(2,016	)		$	4,079			$	607			$	(2,670	)		$	2,723
Comprehensive income (loss) attributable to HCA Healthcare, Inc.		$	2,735			$	(1,974	)		$	4,091			$	565			$	(2,682	)		$	2,735

Schedule of Condensed Consolidating Balance Sheet

HCA HEALTHCARE, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

SEPTEMBER 30, 2019

(Dollars in millions)

		HCA Healthcare, Inc. Issuer				HCA Inc. Issuer				Subsidiary Guarantors				Subsidiary Non- Guarantors				Eliminations				Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents		$	—			$	—			$	130			$	429			$	—			$	559
Accounts receivable			—				—				3,970				3,161				—				7,131
Inventories			—				—				1,154				615				—				1,769
Other			—				—				644				666				—				1,310
			—				—				5,898				4,871				—				10,769
Property and equipment, net			—				—				13,074				8,928				—				22,002
Investments of insurance subsidiaries			—				—				—				357				—				357
Investments in and advances to affiliates			35,590				—				29				214				(35,590	)			243
Goodwill and other intangible assets			—				—				5,719				2,441				—				8,160
Right-of-use operating lease assets			—				—				436				1,334				—				1,770
Other			434				—				34				143				—				611
		$	36,024			$	—			$	25,190			$	18,288			$	(35,590	)		$	43,912
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable		$	—			$	—			$	1,699			$	911			$	—			$	2,610
Accrued salaries			—				—				993				676				—				1,669
Other accrued expenses			15				332				896				1,454				—				2,697
Long-term debt due within one year			—				55				49				44				—				148
			15				387				3,637				3,085				—				7,124
Long-term debt, net			997				32,555				213				332				—				34,097
Intercompany balances			37,967				(5,621	)			(32,198	)			(148	)			—				—
Professional liability risks			—				—				—				1,349				—				1,349
Right-of-use operating lease obligations			—				—				330				1,110				—				1,440
Income taxes and other liabilities			610				11				181				547				—				1,349
			39,589				27,332				(27,837	)			6,275				—				45,359
Stockholders’ (deficit) equity attributable to HCA Healthcare, Inc.			(3,565	)			(27,332	)			52,955				9,967				(35,590	)			(3,565	)
Noncontrolling interests			—				—				72				2,046				—				2,118
			(3,565	)			(27,332	)			53,027				12,013				(35,590	)			(1,447	)
		$	36,024			$	—			$	25,190			$	18,288			$	(35,590	)		$	43,912

HCA HEALTHCARE, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

DECEMBER 31, 2018

(Dollars in millions)

		HCA Healthcare, Inc. Issuer				HCA Inc. Issuer				Subsidiary Guarantors				Subsidiary Non- Guarantors				Eliminations				Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents		$	—			$	—			$	174			$	328			$	—			$	502
Accounts receivable			—				—				3,964				2,825				—				6,789
Inventories			—				—				1,178				554				—				1,732
Other			—				—				669				521				—				1,190
			—				—				5,985				4,228				—				10,213
Property and equipment, net			—				—				12,450				7,307				—				19,757
Investments of insurance subsidiaries			—				—				—				362				—				362
Investments in and advances to affiliates			33,166				—				29				203				(33,166	)			232
Goodwill and other intangible assets			—				—				5,724				2,229				—				7,953
Other			478				64				35				113				—				690
		$	33,644			$	64			$	24,223			$	14,442			$	(33,166	)		$	39,207
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable		$	—			$	—			$	1,721			$	856			$	—			$	2,577
Accrued salaries			—				—				998				582				—				1,580
Other accrued expenses			142				403				905				1,174				—				2,624
Long-term debt due within one year			—				696				55				37				—				788
			142				1,099				3,679				2,649				—				7,569
Long-term debt, net			996				30,544				212				281				—				32,033
Intercompany balances			36,951				(6,789	)			(28,415	)			(1,747	)			—				—
Professional liability risks			—				—				—				1,275				—				1,275
Income taxes and other liabilities			505				—				223				520				—				1,248
			38,594				24,854				(24,301	)			2,978				—				42,125
Stockholders’ (deficit) equity attributable to HCA Healthcare, Inc.			(4,950	)			(24,790	)			48,437				9,519				(33,166	)			(4,950	)
Noncontrolling interests			—				—				87				1,945				—				2,032
			(4,950	)			(24,790	)			48,524				11,464				(33,166	)			(2,918	)
		$	33,644			$	64			$	24,223			$	14,442			$	(33,166	)		$	39,207

Schedule of Condensed Consolidating Statement of Cash Flows

HCA HEALTHCARE, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019

(Dollars in millions)

		HCA Healthcare, Inc. Issuer				HCA Inc. Issuer				Subsidiary Guarantors				Subsidiary Non- Guarantors				Eliminations				Condensed Consolidated
Cash flows from operating activities:
Net income (loss)		$	2,434			$	(2,485	)		$	4,574			$	853			$	(2,504	)		$	2,872
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities			(15	)			(69	)			(137	)			(85	)			—				(306	)
Depreciation and amortization			—				—				1,071				831				—				1,902
Income taxes			51				—				—				—				—				51
Gains on sales of facilities			—				—				(9	)			(8	)			—				(17	)
Losses on retirement of debt			—				211				—				—				—				211
Amortization of debt issuance costs and discounts			—				23				—				—				—				23
Share-based compensation			—				—				263				—				—				263
Equity in earnings of affiliates			(2,504	)			—				—				—				2,504				—
Other			82				—				13				3				—				98
Net cash provided by (used in) operating activities			48				(2,320	)			5,775				1,594				—				5,097
Cash flows from investing activities:
Purchase of property and equipment			—				—				(1,634	)			(1,250	)			—				(2,884	)
Acquisition of hospitals and health care entities			—				—				(39	)			(1,553	)			—				(1,592	)
Disposition of hospitals and health care entities			—				—				31				18				—				49
Change in investments			—				—				1				34				—				35
Other			—				—				(7	)			24				—				17
Net cash used in investing activities			—				—				(1,648	)			(2,727	)			—				(4,375	)
Cash flows from financing activities:
Issuance of long-term debt			—				6,451				—				—				—				6,451
Net change in revolving credit facilities			—				(30	)			—				—				—				(30	)
Repayment of long-term debt			—				(5,213	)			(45	)			(31	)			—				(5,289	)
Distributions to noncontrolling interests			—				—				(79	)			(325	)			—				(404	)
Payment of debt issuance costs			—				(71	)			—				—				—				(71	)
Payment of cash dividends			(414	)			—				—				—				—				(414	)
Repurchases of common stock			(759	)			—				—				—				—				(759	)
Changes in intercompany balances with affiliates, net			1,253				1,183				(4,047	)			1,611				—				—
Other			(128	)			—				—				(17	)			—				(145	)
Net cash (used in) provided by financing activities			(48	)			2,320				(4,171	)			1,238				—				(661	)
Effect on exchange rate changes on cash and cash equivalents			—				—				—				(4	)			—				(4	)
Change in cash and cash equivalents			—				—				(44	)			101				—				57
Cash and cash equivalents at beginning of period			—				—				174				328				—				502
Cash and cash equivalents at end of period		$	—			$	—			$	130			$	429			$	—			$	559

HCA HEALTHCARE, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2018

(Dollars in millions)

		HCA Healthcare, Inc. Issuer				HCA Inc. Issuer				Subsidiary Guarantors				Subsidiary Non- Guarantors				Eliminations				Condensed Consolidated
Cash flows from operating activities:
Net income (loss)		$	2,723			$	(2,016	)		$	4,151			$	956			$	(2,670	)		$	3,144
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities			(15	)			(83	)			(154	)			105				—				(147	)
Depreciation and amortization			—				—				992				705				—				1,697
Gains on sales of facilities			—				—				(378	)			(42	)			—				(420	)
Losses on retirement of debt			—				9				—				—				—				9
Amortization of debt issuance costs			—				23				—				—				—				23
Share-based compensation			—				—				204				—				—				204
Equity in earnings of affiliates			(2,670	)			—				—				—				2,670				—
Other			67				—				—				9				—				76
Net cash provided by (used in) operating activities			105				(2,067	)			4,815				1,733				—				4,586
Cash flows from investing activities:
Purchase of property and equipment			—				—				(1,425	)			(995	)			—				(2,420	)
Acquisition of hospitals and health care entities			—				—				(894	)			(162	)			—				(1,056	)
Disposition of hospitals and health care entities			—				—				770				32				—				802
Change in investments			—				—				19				46				—				65
Other			—				—				(18	)			12				—				(6	)
Net cash used in investing activities			—				—				(1,548	)			(1,067	)			—				(2,615	)
Cash flows from financing activities:
Issuance of long-term debt			—				2,000				—				—				—				2,000
Net change in revolving credit facilities			—				(330	)			—				—				—				(330	)
Repayment of long-term debt			—				(1,566	)			(44	)			(42	)			—				(1,652	)
Distributions to noncontrolling interests			—				—				(63	)			(252	)			—				(315	)
Payment of debt issuance costs			—				(24	)			—				—				—				(24	)
Payment of cash dividends			(366	)			—				—				—				—				(366	)
Repurchases of common stock			(1,195	)			—				—				—				—				(1,195	)
Changes in intercompany balances with affiliates, net			1,697				1,987				(3,167	)			(517	)			—				—
Other			(242	)			—				—				10				—				(232	)
Net cash (used in) provided by financing activities			(106	)			2,067				(3,274	)			(801	)			—				(2,114	)
Effect on exchange rate changes on cash and cash equivalents			—				—				—				(11	)			—				(11	)
Change in cash and cash equivalents			(1	)			—				(7	)			(146	)			—				(154	)
Cash and cash equivalents at beginning of period			1				—				112				619				—				732
Cash and cash equivalents at end of period		$	—			$	—			$	105			$	473			$	—			$	578

X

- Definition

Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 3
-Paragraph i
-Subsection 10

+ Details

Name:	srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix:	srt_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 3
-Paragraph i
-Subsection 10

+ Details

Name:	srt_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix:	srt_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118930883&loc=d3e526-108580

+ Details

Name:	us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration